ID   LOHG-I
AC   CVCL_LI10
DR   cancercelllines; CVCL_LI10
DR   Wikidata; Q54902881
RX   PubMed=10375592;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7010; MEN1; Simple; p.Thr215Serfs*13 (c.643_646delACAG); ClinVar=VCV000200997; Zygosity=Unspecified (PubMed=10375592).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
DI   NCIt; C3225; Multiple endocrine neoplasia type 1
DI   NCIt; C95598; Pancreatic insulinoma
DI   ORDO; Orphanet_652; Multiple endocrine neoplasia type 1
DI   ORDO; Orphanet_97279; Insulinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LI09 ! LOHG-F
OI   CVCL_LI11 ! LOHG-L
OI   CVCL_LI12 ! LOHG-NSA
SX   Male
AG   30Y
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 10
//
RX   PubMed=10375592; DOI=10.3892/ijo.15.1.41;
RA   Sigl E., Behmel A., Henn T., Wirnsberger G.H., Weinhausl A., Kaserer K.,
RA   Niederle B., Pfragner R.;
RT   "Cytogenetic and CGH studies of four neuroendocrine tumors and
RT   tumor-derived cell lines of a patient with multiple endocrine
RT   neoplasia type 1.";
RL   Int. J. Oncol. 15:41-51(1999).
//